16 February, 2025
The treat-to-target approach offers a promising framework for improving the management of GCA and PMR. By setting clear treatment goals, regularly monitoring disease activity, and adjusting therapies based on individual patient needs, clinicians can better control these chronic conditions and minimize treatment-related complications.
06 December 2022
According to data from a phase 2 trial, researchers have discovered inflammatory markers that may help identify COVID-19 patients who are more likely to react to treatments like the anti-cancer medicine pacritinib…
Norberto, a 23-year old white male in his third relapse of a B cell acute lymphoblastic leukemia (B-ALL) has been treated with an infusion of autologous CD19 Chimeric Antigen Receptor (CAR) T cells (CAR-T cells). Ten days later, he felt severe discomfort in the middle of the night…
14th May
Did you watch the IUIS Webinar : “What cancer immunologists are doing about COVID-19?” by Rachel Humphrey, a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. Highlights from her talk include: Intersection in advances in cancer and infectious diseases immunology…
25th March
Mehat, P. et al recently stated that there is accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have cytokine storm syndrome. Immunosuppression treatment could help severe COVID-19 patients.
A 33 year old male presents with a one month history of a non-productive cough, fever, night sweats, malaise, abdominal pain and weight loss. History: Known HIV positive, Diagnosed 8 months previously but not on ARV’s. Past medical history: Nothing of significance